We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




5G-Enabled Robotic Surgery Ushers in New Era in Gastric Cancer Treatment

By HospiMedica International staff writers
Posted on 27 Feb 2024

Gastric cancer ranks as the fifth most prevalent cancer in the world and is the fourth leading cause of cancer-related deaths. More...

This alarming statistic highlights the critical need for innovative advancements in cancer care, especially considering the significant disparities in access to diagnostic and treatment facilities in remote and underserved regions. In a groundbreaking development, researchers have successfully performed the first robot-assisted remote radical distal gastrectomy using 5G communication technology. Although the efficacy of 5G technology has been proven in other medical specialties like urology and orthopedics, its application in gastric surgery has been confined to preclinical trials involving animals and cadavers until now.

The pioneering procedure was conducted at the Third Department of Surgery, the Fourth Hospital of Hebei Medical University (Shijiazhuang, China) on a 51-year-old patient diagnosed with stage T2N0M0 gastric cancer, using the Tuomai four-arm laparoscopic robotic surgery system. The surgery demonstrated remarkable outcomes, including negligible intraoperative delays and zero packet loss, demonstrating the immense potential of 5G technology in enhancing remote surgical procedures. The patient’s rapid and complication-free recovery further confirmed the safety and efficacy of this novel procedure.

“This is the initial clinical experience of this new technology, and preliminarily verified the feasibility and safety,” said Professor Zhao, lead researcher of the study. “We believe that the findings from this study lay a solid foundation for the future of telemedicine in treating patients with gastric cancer.”

Related Links:
Hebei Medical University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.